Haplo Therapeutics

Haplo Therapeutics is a biotech company focused on advancing therapeutic treatments for rare genetic diseases, with an emphasis on those that are rooted in haploinsufficiency.  The company is screening thousands of compounds, including approved and clinical-stage drugs, with the aim of identifying modulators of the TCF4 gene.  The goal is to bring forward candidate drugs for clinical trials.